• Thumbnail for Novartis
    Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one...
    144 KB (12,146 words) - 09:25, 31 October 2024
  • Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name...
    35 KB (2,760 words) - 06:06, 18 October 2024
  • The Novartis Foundation (formerly known as the Novartis Foundation for Sustainable Development) is a non-profit organization and part of the corporate...
    5 KB (488 words) - 07:51, 21 April 2024
  • Thumbnail for Ovaltine
    acquired the brand from Novartis in 2002, except in the United States, where Nestlé acquired the rights separately from Novartis in the late 2000s. Ovaltine...
    15 KB (1,544 words) - 00:45, 17 October 2024
  • Thumbnail for Novartis v. Union of India & Others
    Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent...
    43 KB (5,300 words) - 23:28, 21 October 2024
  • AveXis was acquired by Novartis in 2018 for USD 8.7 billion. In September 2020, Novartis changed the company's name to Novartis Gene Therapies. In 2019...
    10 KB (784 words) - 22:30, 12 September 2024
  • Thumbnail for Excedrin (brand)
    majority ownership through a joint venture transaction with Novartis. On January 9, 2012, Novartis announced that it was voluntarily recalling all lots of...
    14 KB (1,370 words) - 22:49, 11 October 2024
  • Thumbnail for Alcon
    Alcon (category Novartis)
    2008, Novartis purchased approximately 25% of Nestlé's stake in Alcon, with an option to buy Nestlé's remaining shares beginning in 2010. Novartis bought...
    13 KB (966 words) - 07:56, 21 October 2024
  • Thumbnail for Vasant Narasimhan
    Vasant Narasimhan (category Novartis people)
    officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey Swiss Intel, canlgnd before joining Novartis in 2005...
    22 KB (1,892 words) - 02:29, 30 October 2024
  • Thumbnail for Imatinib
    Imatinib (category Drugs developed by Novartis)
    sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer...
    71 KB (6,702 words) - 05:32, 9 August 2024